
MP265
CAS No. 544-47-8
MP265( MP-265 | MP 265 | S-(4-Chlorobenzyl)Isothiouronium chloride )
Catalog No. M27780 CAS No. 544-47-8
MP265 disrupts the MreB cytoskeleton and has antiproliferative effects.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 45 | Get Quote |
![]() ![]() |
10MG | 63 | Get Quote |
![]() ![]() |
25MG | 103 | Get Quote |
![]() ![]() |
50MG | 150 | Get Quote |
![]() ![]() |
100MG | 223 | Get Quote |
![]() ![]() |
500MG | 482 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameMP265
-
NoteResearch use only, not for human use.
-
Brief DescriptionMP265 disrupts the MreB cytoskeleton and has antiproliferative effects.
-
DescriptionMP265 disrupts the MreB cytoskeleton and has antiproliferative effects.(In Vitro):In MCF-7 cells, conjugate MP265 showed higher antiproliferative effect than paclitaxel alone. Receptor saturation tests showed that the unconjugated peptide analog of GnRH decreased efficacy of conjugate MP265 in concentration- and time-dependent manner.
-
In Vitro——
-
In Vivo——
-
SynonymsMP-265 | MP 265 | S-(4-Chlorobenzyl)Isothiouronium chloride
-
PathwayOthers
-
TargetOther Targets
-
RecptorPin1, Pin4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number544-47-8
-
Formula Weight237.14
-
Molecular FormulaC8H10Cl2N2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.NC(=N)SCc1ccc(Cl)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Uchida T, et al. Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation. Chem Biol. 2003 Jan;10(1):15-24.
molnova catalog



related products
-
1beta-Hydroxyalantol...
1beta-Hydroxyalantolactone has protective effect against AD-like skin inflammation, can as a potential therapeutic agent for AD.
-
Carbadox
An antibacterial agent that has been used in veterinary practice for treating swine dysentery and enteritis and for promoting growth.
-
3-Methyladipic acid
3-Methyladipic acid is a metabolite of the catabolism of phytanic acid. Patients with adult Refsums disease (ARD) are unable to detoxify phytanic acid by alpha-oxidation and so the w-oxidation pathway is the only metabolic pathway available for phytanic acid degradation.